Q1. How many patients have you treated (using surgery, radiotherapy or any systemic anti-cancer therapy) in the last three months for:
• Breast cancer (any stage)
• Early breast cancer (both early-stage and locally advanced, inclusive of stages I-IIIC)
• Metastatic breast cancer (stage IV)
Q2. How many patients have been treated for breast cancer (any stage) in the past 3 months with the following systemic anti-cancer therapies:
• Abemaciclib + Aromatase Inhibitor (e.g. anastrazole, exemestane, letrozole)
• Abemaciclib + Fulvestrant
• Anthracycline (e.g. doxorubicin or epirubicin) as a single agent
• Atezolizumab +Nab-paclitaxel/Paclitaxel
• Capecitabine as a single agent
• Carboplatin or Cisplatin as a single agent
• Eribulin as a single agent or in combination
• Everolimus + Exemestane
• Fluorouracil
• Fulvestrant as a single agent
• Lapatinib
• Neratinib
• Olaparib
• Palbociclib + Aromatase Inhibitor (e.g. anastrazole, exemestane, letrozole)
• Palbociclib + Fulvestrant
• Pertuzumab + Trastuzumab + Docetaxel
• Platinum (e.g. carboplatin or cisplatin) as a single agent
• Ribociclib + Aromatase Inhibitor (e.g. anastrazole, exemestane, letrozole)
• Ribociclib + Fulvestrant
• Talazoparib
• Taxane (e.g. docetaxel, paclitaxel, nab-paclitaxel) as a single agent
• Transtuzumab as a single agent or in combination
• Trastuzumab emtansine
• Any other active systemic anti-cancer therapy
Organisations information technology infrastructure equipment
Information in relation Doctor/Consultant vacancies
Information in relation to the Radiology equipment at the Trust
Information in relation to the Radiology equipment at the Trust - DATA
This is an information request relating to monies given to Stonewall.
Please provide the following information:
1. What was the membership fee given to Stonewall as part of their Diversity Champions programme in each of 2018-19, 2019-20 and 2020-21 by your organisation?
Information in relation to Network and Telecoms contracts at Velindre
Information in relation to Network and Telecoms contracts at Velindre - DATA
Information in relation to to Digital Dictation and Voice Recognition systems within the Trust.
Information in relation to to Digital Dictation and Voice Recognition systems within the Trust - DATA
Information relating to empty buildings & their value within Velindre University NHS Trust
Information in relation to the ICT expenditure at Velindre
Information in relation to the ICT expenditure at Velindre DATA 1
Information in relation to the ICT expenditure at Velindre DATA 2
Information in relation to temporary staff spend and waiting list initiative and overtime spend in 20/21 at Velindre
- Information in relation to temporary staff spend and waiting list initiative and overtime spend in 20/21 at Velindre DATA